These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7709097)

  • 1. [Hemolytic activity of various strains and clones of Trichomonas vaginalis and Tritrichomonas suis].
    De Carli G; Brasseur P; Rott M; da Silva A; Wendorff A
    Rev Latinoam Microbiol; 1994; 36(3):207-11. PubMed ID: 7709097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic activity of Trichomonas vaginalis and Tritrichomonas foetus.
    De Carli GA; Brasseur P; da Silva AC; Wendorff A; Rott M
    Mem Inst Oswaldo Cruz; 1996; 91(1):107-10. PubMed ID: 8734959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tritrichomonas foetus: a scanning electron microscopy study of erythrocyte adhesion associated with hemolytic activity.
    De Carli GA; Tasca T; Pires Borges F
    Vet Res; 2004; 35(1):123-30. PubMed ID: 15099509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Tritrichomonas foetus and Tritrichomonas suis synonyms?
    Lun ZR; Chen XG; Zhu XQ; Li XR; Xie MQ
    Trends Parasitol; 2005 Mar; 21(3):122-5. PubMed ID: 15734659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effect of 2,4-dinitro-phenyl-substituted sugar hydrazones and phenylosazone against Trichomonas vaginalis and Tritrichomonas foetus.
    Macicková T; Kettner M; Linek K
    Pharmazie; 1990 Mar; 45(3):204-6. PubMed ID: 2381964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virulence of Trichomonas vaginalis strains in relation to clinical forms of Trichomonas vaginitis].
    Małyszko E; Januszko T; Smorczewska-Czupryńska B; Ustymowicz-Farbiszewska J
    Wiad Parazytol; 1991; 37(2):219-23. PubMed ID: 1822038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females.
    Valadkhan Z; Sharma S; Harjai K; Gupta I; Malla N
    Indian J Pathol Microbiol; 2003 Oct; 46(4):693-9. PubMed ID: 15025385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-hemolytic activity of Trichomonas vaginalis correlates with virulence.
    Krieger JN; Poisson MA; Rein MF
    Infect Immun; 1983 Sep; 41(3):1291-5. PubMed ID: 6604026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of zymodeme patterns, virulence & drug sensitivity of Trichomonas vaginalis isolates from women.
    Vohra H; Sharma P; Sofi BA; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Indian J Med Res; 1991 Jan; 93():37-9. PubMed ID: 2022400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of erythrocytes by Trichomonas gallinae.
    De Carli GA; da Silva AC; Wendorff A; Rott M
    Avian Dis; 1996; 40(1):228-30. PubMed ID: 8713039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
    Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
    J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic activity of Trichomonas gallinae isolates does not correspond with clinical virulence.
    Gerhold RW; Yabsley MJ; Fischer JR
    Vet Parasitol; 2009 Mar; 160(3-4):221-4. PubMed ID: 19097703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pathogenicity of Trichomonas vaginalis isolated from symptomatic and asymptomatic cases.
    Bhatt R; Pandit D; Deodhar L; Bhise R; Chatterjee DK
    J Postgrad Med; 1993; 39(4):187-9. PubMed ID: 7996493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes.
    Rendón-Maldonado JG; Espinosa-Cantellano M; González-Robles A; Martínez-Palomo A
    Exp Parasitol; 1998 Jun; 89(2):241-50. PubMed ID: 9635448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an animal model of trichomoniasis as a basis for understanding this disease in women.
    Corbeil LB
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S158-61. PubMed ID: 8845444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pathogenicity of trichomonas vaginalis isolated from symptomatic & asymptomatic cases.
    Bhatt R; Deodhar L; Pandit D; Bhise R; Chatterjee DK
    J Postgrad Med; 1997; 43(3):68-70. PubMed ID: 10740726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iron on the virulence of Trichomonas vaginalis.
    Ryu JS; Choi HK; Min DY; Ha SE; Ahn MH
    J Parasitol; 2001 Apr; 87(2):457-60. PubMed ID: 11318588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
    Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
    J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flagellated parasite Trichomonas vaginalis: new insights into cytopathogenicity mechanisms.
    Fiori PL; Rappelli P; Addis MF
    Microbes Infect; 1999 Feb; 1(2):149-56. PubMed ID: 10594979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of nitrofuran and asymmetrically substituted urea on Trichomonas vaginalis and Tritrichomonas foetus in vitro and in vivo].
    Macicková T; Kettner M; Benes L
    Bratisl Lek Listy; 1990 Jan; 91(1):30-7. PubMed ID: 2322865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.